New investment vehicle aims to empower early-stage healthcare companies with a focus on improving access, affordability, and quality of care
Experienced Leadership at the Helm
Healthcare-focused investment firm HealthKois has officially launched a $300 million healthcare transformation fund, accompanied by an additional $100 million green shoe option. The fund is spearheaded by the founding team behind HealthQuad, Charles Janssen (Managing Partner), Ajay Mahipal (Partner), and Dr. Pinak Shrikhande (Partner).
HealthQuad’s prior funds have impacted over 90 million lives and served more than 8 million patients annually, providing a strong foundation for HealthKois’s new initiative.
Targeting Early Growth-Stage Healthcare Companies
HealthKois will focus on early growth-stage companies operating across several sectors, including healthtech, life sciences, medtech, healthcare delivery, and the emerging field of climate health. The fund plans to invest between $7 million and $25 million per company over the next four years.
The emphasis is on businesses that have demonstrated proven clinical outcomes, scalable operations, and sustainable infrastructure, ensuring investments are made in ventures with the potential for long-term impact.
Also Read: Biscuit Giant Sends Legal Notice to Prashant Desai Over Palm Oil Claims
A Hands-On, Founder-First Approach
In addition to providing capital, HealthKois also provide strategic advice, enter the market with partners, and ultimately help with the governance of a company. With a team with over 100 years of combined experience in clinical care, operations, and healthcare investing, HealthKois is committed to supporting the founders in a close partnership to steer through unlimited growth challenges.
“We aim to be more than just investors; we are strategic partners dedicated to driving healthcare innovation,” said Ajay Mahipal.
Aligning with Global Healthcare Innovation Trends
Global healthtech funding has surged in recent years, reaching a record $72 billion in 2023, as per CB Insights. The pandemic accelerated the adoption of digital health solutions, telemedicine, and remote monitoring, areas that HealthKois plans to nurture.
Including climate health in its portfolio further reflects the fund’s understanding of the increasing impact of environmental factors on public health.
Building on Proven Success
HealthKois builds on the achievements of HealthQuad Funds I and II, which invested in over 30 companies globally. Notable portfolio companies include SigTuple (AI-driven diagnostics), Innovaccer (health data platform), and MedGenome (genomics), all contributing to millions of patients’ well-being.
Commitment to Sustainability and Real-World Impact
HealthKois integrates environmental, social, and governance (ESG) principles within its investment framework. By supporting innovations addressing climate-health intersections, the fund is positioning itself at the forefront of sustainable healthcare transformation.
Transforming Healthcare Access and Quality
With substantial capital, an experienced team, and a detailed plan, HealthKois will help speed up healthcare innovation across Asia, Europe and other countries build a successful healthtech startup. Their focus on scalable and clinically proven, sustainable healthcare solutions will enhance access, affordability and quality of health care and patient care worldwide.
Also Read: Kosmc AI Secures $200K Pre-Seed Funding to Empower Social Commerce
